Browse the latest research summaries in the field of genetics for spinal cord injury patients and caregivers.
Showing 251-260 of 1,773 results
Child's Nervous System, 2022 • July 30, 2022
This case report describes an 11-year-old girl with achondroplasia who presented with symptoms suggestive of worsening lumbar stenosis. However, she was subsequently diagnosed with myasthenia gravis. ...
KEY FINDING: This paper reports the first documented case of myasthenia gravis occurring in a patient with achondroplasia.
European Journal of Medical Research, 2022 • August 4, 2022
This study analyzes gene expression changes in two different rat models of spinal cord injury (SCI) using RNA sequencing. The researchers found distinct gene expression patterns in the two SCI models,...
KEY FINDING: The study identified significant differences in gene expression between the two SCI models, particularly within the first two weeks after injury.
J. Biol. Chem., 2022 • August 31, 2022
This study investigates the role of Triad1 in promoting astrocyte-dependent neurite outgrowth to accelerate recovery after spinal cord injury (SCI) by inhibiting MDM2-mediated PTN ubiquitination. The ...
KEY FINDING: Triad1 overexpression promoted PTN protein levels, NGF expression, BDNF expression, astrocyte and neuronal viability, and neurite outgrowth but suppressed astrocyte apoptosis.
PLOS ONE, 2022 • September 6, 2022
This study aimed to investigate the effects of miR-31 on the migration of bone marrow mesenchymal stem cells (BMSCs) and the regulation of MMP-2 and CXCR4 expression in vitro and in vivo. In vitro exp...
KEY FINDING: MiR-31 promotes the proliferation of BMSCs in vitro, as demonstrated by CCK-8 and Cell-cycle assays.
Cells, 2022 • August 29, 2022
This review highlights the significant role of inflammation in the pathophysiology of SCI and the urgent need for effective treatments. The authors discuss various therapeutic strategies to regulate t...
KEY FINDING: Inflammation following SCI is a complex process with both beneficial and detrimental effects, requiring careful modulation for effective treatment.
Int. J. Mol. Sci., 2022 • August 23, 2022
This study investigates the effects of recombinant human erythropoietin (rhEPO) and carbamylated EPO (cEPO-Fc) on mice after spinal cord ischemia (SCI) and the prognostic value of sphingosin-1-phospha...
KEY FINDING: Treatment with rhEPO and cEPO-Fc significantly improves the neurological outcome of mice after spinal cord ischemia.
Frontiers in Genetics, 2022 • August 23, 2022
Exosomes are nano-vesicles involved in cell-to-cell communication, impacting processes like cell proliferation, migration, and angiogenesis, with implications for various diseases, including orthopedi...
KEY FINDING: Mesenchymal stem cell (MSC) exosomes participate in tissue repair and injury processes, suggesting their potential as drug carriers. Macrophage-derived exosomes can affect the tissue microenvironment by modulating immune function and tend to accumulate in cancer cells due to specific surface proteins.
J Clin Invest, 2022 • November 1, 2022
This study identifies microvascular defects in SMA patients, transgenic SMA mice, and cellular models with SMN deficiency. It reveals a widespread microvascular pathology that is amenable to systemica...
KEY FINDING: SMA patients exhibit retinal vascular defects, characterized by a less dense and less complex primary retinal vasculature compared to age-matched controls.
Journal of Advanced Research, 2022 • December 22, 2022
This review provides an overview of the necroptosis signaling pathway and execution in the context of CNS trauma. The review discusses the temporal pattern of RIPK1/3 expression following CNS trauma, ...
KEY FINDING: RIPK1, RIPK3, and MLKL expression increases in the hours to days after TBI, but the temporal patterns of these proteins differ between SCI and TBI.
Cells, 2022 • September 8, 2022
This study investigates the neuroprotective effects of melatonin on spinal cord injury (SCI) in mice, focusing on the Nrf2/ARE/NLRP3 pathway. The results demonstrate that melatonin promotes neuromotor...
KEY FINDING: Melatonin promotes the recovery of neuromotor function by inhibiting neuroinflammation and reducing neuronal death.